Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Angela Farngren"'
Autor:
Javier Oliver, Juan Luis Onieva, Maria Garrido-Barros, Miguel-Ángel Berciano-Guerrero, Alfonso Sánchez-Muñoz, María José Lozano, Angela Farngren, Martina Álvarez, Beatriz Martínez-Gálvez, Elisabeth Pérez-Ruiz, Emilio Alba, Manuel Cobo, Antonio Rueda-Domínguez, Isabel Barragán
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2419 (2022)
Cutaneous melanoma (CM) is the most lethal form of skin cancer if it becomes metastatic, where treatment options and survival chances decrease dramatically. Immunotherapy treatments based on the immunologic checkpoint inhibitors programmed death cell
Externí odkaz:
https://doaj.org/article/22f70c950b1644fb919c4d1e09a270aa
Autor:
Juan Luis Onieva, Qingyang Xiao, Miguel-Ángel Berciano-Guerrero, Aurora Laborda-Illanes, Carlos de Andrea, Patricia Chaves, Pilar Piñeiro, Alicia Garrido-Aranda, Elena Gallego, Belén Sojo, Laura Gálvez, Rosario Chica-Parrado, Daniel Prieto, Elisabeth Pérez-Ruiz, Angela Farngren, María José Lozano, Martina Álvarez, Pedro Jiménez, Alfonso Sánchez-Muñoz, Javier Oliver, Manuel Cobo, Emilio Alba, Isabel Barragán
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9124 (2022)
Resistance to Immune Checkpoint Blockade (ICB) constitutes the current limiting factor for the optimal implementation of this novel therapy, which otherwise demonstrates durable responses with acceptable toxicity scores. This limitation is exacerbate
Externí odkaz:
https://doaj.org/article/5fcf3b37b8984f97b39c6a26a3167784
Autor:
Javier Oliver, Juan Luis Onieva, Maria Garrido-Barros, Miguel Berciano-Guerrero, Alfonso Sánchez, Maria Jose Lozano, Angela Farngren, Martina Álvarez, Beatriz Martinez-Galvez, Elisabeth Pérez, Emilio Alba, Manuel Cobo-Dols, Antonio Rueda-Dominguez, Isabel Barragán
Cutaneous Melanoma (CM) is the most lethal form of skin cancer if it becomes metastatic, where treatment options and survival chances decrease dramatically. Immunotherapy treatments based on the immunologic checkpoint inhibitors (PD-1 and CTLA4) cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1dcf8c612331486d94736cdc7af81cb
Autor:
Onieva, Juan Luis1,2,3,4 (AUTHOR), Xiao, Qingyang5,6 (AUTHOR), Berciano-Guerrero, Miguel-Ángel1,3 (AUTHOR), Laborda-Illanes, Aurora1,2,3,4 (AUTHOR), de Andrea, Carlos7,8 (AUTHOR), Chaves, Patricia1,2,3 (AUTHOR), Piñeiro, Pilar1,2,3 (AUTHOR), Garrido-Aranda, Alicia1,2,3 (AUTHOR), Gallego, Elena3,9 (AUTHOR), Sojo, Belén1,2,3 (AUTHOR), Gálvez, Laura1,3 (AUTHOR), Chica-Parrado, Rosario1,2,3 (AUTHOR), Prieto, Daniel3,9 (AUTHOR), Pérez-Ruiz, Elisabeth1,3 (AUTHOR), Farngren, Angela6 (AUTHOR), Lozano, María José3,10 (AUTHOR), Álvarez, Martina1,2,3 (AUTHOR), Jiménez, Pedro1,3 (AUTHOR), Sánchez-Muñoz, Alfonso1,3 (AUTHOR), Oliver, Javier1,2,3 (AUTHOR) javier.oliver@ibima.eu
Publikováno v:
International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 16, p9124-N.PAG. 22p.
Autor:
Oliver, Javier, Onieva, Juan Luis, Garrido-Barros, Maria, Berciano-Guerrero, Miguel-Ángel, Sánchez-Muñoz, Alfonso, José Lozano, María, Farngren, Angela, Álvarez, Martina, Martínez-Gálvez, Beatriz, Pérez-Ruiz, Elisabeth, Alba, Emilio, Cobo, Manuel, Rueda-Domínguez, Antonio, Barragán, Isabel
Publikováno v:
Biomedicines; Oct2022, Vol. 10 Issue 10, pN.PAG-N.PAG, 18p